Yizhe Wu
Head of Drug Discovery HealZen Therapeutics Co., Ltd.
Dr.WuYizhe is the head of drug discovery at HealZen Therapeutic with 10 years of experience in innovative drug. Dr.Wu specialized in development of small molecule inhibitor and protein degrader targeting oncology and immune & I inflammation diseases. Dr.Wu holds a Ph.D degree in chemistry from university of HongKong and has led the development of 5 drug candidates into clinical stage.
Seminars
Wednesday 9th September 2026
Advancing Next-Generation Pan-RAS Targeting for Broad & Durable Control of RAS-Driven Cancers
2:00 pm
- Mapping the global pan-RAS competitive landscape and defining remaining biological and clinical gaps beyond first-generation RAS(ON) and allele-selective inhibitors, highlighting opportunities for differentiated therapeutic strategies
- Leveraging a proprietary molecular-glue discovery platform to identify distinct PPI and enabling identification of differentiated next-generation pan-RAS inhibitors with best-in-class potential
- Demonstrating the therapeutic promise of Healzen Therapeutics’ pan-RAS program through key preclinical insights and program highlights supporting broad activity, improved durability, and competitive differentiation across RAS-driven cancers
